You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 6
  • 12 Medical cannabis for children with autistic spectrum disorder: is there a difference between those treated with cannabis as monotherapy vs those treated with cannabis and concomitant conventional medications?

Article info

Article menu

Download PDFPDF

D) Session 6: Drugs in Special Populations and Settings II: Pharmacology of ECMO and other Extracorporeal Devices
12 Medical cannabis for children with autistic spectrum disorder: is there a difference between those treated with cannabis as monotherapy vs those treated with cannabis and concomitant conventional medications?
Free

Authors

Citation

Dagan A, Stolar O, Kohn E, et al
12 Medical cannabis for children with autistic spectrum disorder: is there a difference between those treated with cannabis as monotherapy vs those treated with cannabis and concomitant conventional medications?
BMJ Paediatrics Open 2024;8:doi: 10.1136/bmjpo-2024-ESDPPP.11

Publication history

  • First published July 31, 2024.
Online issue publication 
July 31, 2024

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ.